Literature DB >> 11949208

Management of malaria in Thailand.

Udomsak Silachamroon1, Srivicha Krudsood, Nanthaphorn Phophak, Sornchai Looareesuwan.   

Abstract

The purpose of treatment for uncomplicated malaria is to produce a radical cure using the combination of: artesunate (4 mg/kg/day) plus mefloquine (8 mg/kg day) for 3 days: a fixed dose of artemether and lumefantrine (20/120 mg tablet) named Coartem (4 tablets twice a day for three days for adults weighing more than 35 kg): quinine 10 mg/kg 8-hourly plus tetracycline 250 mg 6-hourly for 7 days (or doxycycline 200 mg as an alternative to tetracycline once a day for 7 days) in patients aged 8 years and over: Malarone (in adult 4 tablets daily for 3 days). In treating severe malaria, early diagnosis and treatment with a potent antimalarial drug is recommended to save the patient's life. The antimalarial drugs of choice are: intravenous quinine or a parenteral form of an artemisinin derivative (artesunate i.v./i.m. for 2.4 mg/kg followed by 1.2 mg/kg injection at 12 and 24 hr and then daily for 5 dayss; artemether i.m. 3.2 mg/kg injection followed by 1.6 mg/kg at 12 and 24 hrs and then daily for 5 days; artemether i.m. (Artemotil) with the same dose of artemether or artesunate suppository (5 mg/kg) given rectally 12 hourly for 3 days. Oral artemisinin derivatives (artesunate, artemether, and dihydroartemisinin with 4 mg/kg/day) could replace parenteral forms when patients can tolerate oral medication. Oral mefloquine (25 mg/kg divided into two doses 8 hrs apart) should be given at the end of the artemisinin treatment course to reduce recrudescence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949208      PMCID: PMC2721050          DOI: 10.3347/kjp.2002.40.1.1

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  24 in total

1.  A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.

Authors:  S Looareesuwan; P Wilairatana; W Chokejindachai; K Chalermrut; W Wernsdorfer; B Gemperli; I Gathmann; C Royce
Journal:  Am J Trop Med Hyg       Date:  1999-02       Impact factor: 2.345

Review 2.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

3.  Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand.

Authors:  P Wilairatna; S Krudsood; U Silachamroon; P Singhasivanon; S Vannaphan; S Faithong; M Klabprasit; S N Bangchang; P Olliaro; S Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.345

Review 4.  Consensus recommendation on the treatment of malaria in Southeast Asia.

Authors:  S Looareesuwan; P Olliaro; N J White; T Chongsuphajaisiddhi; A Sabcharoen; K Thimasarn; F Nosten; P Singhasivanon; S Supavej; S Khusmith; S Wylings; T Kanyok; D Walsh; P A Leggat; E B Doberstyn
Journal:  Southeast Asian J Trop Med Public Health       Date:  1998-06       Impact factor: 0.267

5.  Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.

Authors:  S Looareesuwan; B Oosterhuis; B M Schilizzi; F A E Sollie; P Wilairatana; S Krudsood; Ch B Lugt; P A M Peeters; J O Peggins
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

6.  Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand.

Authors:  S Looareesuwan; P Wilairatana; R Glanarongran; K A Indravijit; L Supeeranontha; S Chinnapha; T R Scott; J D Chulay
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Nov-Dec       Impact factor: 2.184

7.  Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.

Authors:  S Looareesuwan; P Wilairatana; K Chalermarut; Y Rattanapong; C J Canfield; D B Hutchinson
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

8.  Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.

Authors:  M V Vugt; P Wilairatana; B Gemperli; I Gathmann; L Phaipun; A Brockman; C Luxemburger; N J White; F Nosten; S Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  1999-06       Impact factor: 2.345

9.  Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.

Authors:  D S Walsh; S Looareesuwan; P Wilairatana; D G Heppner; D B Tang; T G Brewer; W Chokejindachai; P Viriyavejakul; D E Kyle; W K Milhous; B G Schuster; J Horton; D J Braitman; R P Brueckner
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

Review 10.  Malaria: new developments in treatment and prevention.

Authors:  P Newton; N White
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.